Your specialists for market access and reimbursement
HS Value & Dossier GmbH
We offer you health policy solutions for all phases of the product life cycle
From study design to price negotiation
A new product has only one chance to enter the market successfully
We help you with passion to master the challenges of health policy
Market Access & Reimbursement for Pharmaceuticals and Medical Devices
Market access and reimbursement of drugs and medical devices are subject to complex legal and regulatory requirements. A key feature is that initial market access requires a benefit assessment by the competent institutions, which either represents an entry barrier in the sense of a fourth hurdle, or serves as a prerequisite for price negotiations. In principle, it can be assumed that a „Health Technology Assessment“ is necessary for all medical services that are newly included in the catalogue of services of the statutory health insurance, i.e. a form of benefit assessment according to the criteria of evidence-based medicine. However, the processes vary depending on the product and performance range.
Market access and reimbursement of drugs in Germany
Market access and reimbursement of medical devices
„Our claim is individual, company-specific solutions that concentrate on the value of the products and implement this within the framework of the required benefit dossiers“
Dr. Willi Schnorpfeil
HS Value & Dossier GmbH advises innovative pharmaceutical companies and biotechnology companies in the AMNOG process. With our many years of expertise, our experienced employees, and our versatile partners, we support you in strategy development, in the preparation of your benefit dossier for the G-BA evaluation, and in price negotiations with the GKV central association. Motivation and objective is always the optimized reimbursement for your new product. The focus here is on detailed process experience and innovative, interdisciplinary approaches.